XML 141 R124.htm IDEA: XBRL DOCUMENT
v3.25.1

Credit risk exposure and allowances - Allowances, Financial Assets (Details) - ARS ($) $ in Thousands | 12 Months Ended |
--- | --- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Financial assets | $ 15,350,501,149 | $ 11,753,183,986 |
Credits recovered | 89,577,386 | 78,055,496 |
Allowances for ECL | Financial Assets |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Financial assets | 258,080,214 | 211,417,546 | $ 279,340,372
New financial assets originated | 282,908,660 | 301,310,311 |
Repayments | (126,012,689) | (227,702,377) |
Write-offs | (52,191,971) | (58,348,740) |
Foreign exchange | 2,413,102 | 24,109,792 |
Inflation adjustment | (163,386,750) | (298,636,654) |
Allowances for ECL | Financial Assets | Transfers from Stage 1 to Stage 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 31,801,620 | 66,158,968 |
Allowances for ECL | Financial Assets | Transfers from Stage 2 to Stage 1 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (12,511,872) | (30,762,566) |
Allowances for ECL | Financial Assets | Transfers from Stage 1 or 2 to Stage 3 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 74,915,095 | 63,630,543 |
Allowances for ECL | Financial Assets | Transfers from Stage 3 to Stage 1 or 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (8,906,906) | (16,405,809) |
Allowances for ECL | Financial Assets | Changes without transfers between Stages |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 17,634,379 | 108,723,706 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Financial assets | 55,376,957 | 40,349,027 | 46,335,924
New financial assets originated | 97,090,358 | 176,176,225 |
Repayments | (55,646,807) | (152,844,477) |
Write-offs | 0 | 0 |
Foreign exchange | 1,577,358 | 18,397,094 |
Inflation adjustment | (24,816,666) | (48,426,684) |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Transfers from Stage 1 to Stage 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (16,124,291) | (22,774,025) |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Transfers from Stage 2 to Stage 1 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 5,250,908 | 10,020,586 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Transfers from Stage 1 or 2 to Stage 3 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (1,261,890) | (1,220,560) |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Transfers from Stage 3 to Stage 1 or 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 109,116 | 376,690 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Changes without transfers between Stages |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 8,849,844 | 14,308,254 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (collectively assessed) |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Financial assets | 78,959,966 | 49,314,954 | 61,356,726
New financial assets originated | 12,099,402 | 10,347,983 |
Repayments | (19,593,514) | (19,509,676) |
Write-offs | (50,406,351) | (56,211,057) |
Foreign exchange | 5,353 | 20,269 |
Inflation adjustment | (35,938,448) | (73,404,713) |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (collectively assessed) | Transfers from Stage 1 to Stage 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 0 | 0 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (collectively assessed) | Transfers from Stage 2 to Stage 1 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 0 | 0 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (collectively assessed) | Transfers from Stage 1 or 2 to Stage 3 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 102,528,347 | 108,913,847 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (collectively assessed) | Transfers from Stage 3 to Stage 1 or 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (9,484,619) | (14,913,737) |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (collectively assessed) | Changes without transfers between Stages |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 30,434,842 | 32,715,312 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (individually assessed) |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Financial assets | 3,905,668 | 5,980,333 | 7,581,630
New financial assets originated | 236,944 | 2,803,528 |
Repayments | (468,675) | (4,297,979) |
Write-offs | (1,785,614) | (2,137,681) |
Foreign exchange | 663,655 | 4,587,074 |
Inflation adjustment | (3,545,748) | (7,113,151) |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (individually assessed) | Transfers from Stage 1 to Stage 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 0 | 0 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (individually assessed) | Transfers from Stage 2 to Stage 1 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 0 | 0 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (individually assessed) | Transfers from Stage 1 or 2 to Stage 3 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 2,829 | 3,222,910 |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (individually assessed) | Transfers from Stage 3 to Stage 1 or 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (100,109) | (2,760,528) |
Allowances for ECL | Financial Assets | Stage 1 and Stage 3 | Credit risk exposure (individually assessed) | Changes without transfers between Stages |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 2,922,053 | 4,094,530 |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (collectively assessed) |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Financial assets | 118,829,185 | 115,542,361 | 163,250,849
New financial assets originated | 173,353,583 | 110,014,971 |
Repayments | (50,138,632) | (49,123,387) |
Write-offs | (6) | (2) |
Foreign exchange | 126,854 | 721,777 |
Inflation adjustment | (98,908,242) | (168,971,538) |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (collectively assessed) | Transfers from Stage 1 to Stage 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 47,578,081 | 88,932,978 |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (collectively assessed) | Transfers from Stage 2 to Stage 1 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (17,717,381) | (40,738,217) |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (collectively assessed) | Transfers from Stage 1 or 2 to Stage 3 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (26,350,084) | (47,120,627) |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (collectively assessed) | Transfers from Stage 3 to Stage 1 or 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 568,706 | 928,296 |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (collectively assessed) | Changes without transfers between Stages |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (25,226,055) | 57,647,261 |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (individually assessed) |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Financial assets | 1,008,438 | 230,871 | $ 815,243
New financial assets originated | 128,373 | 1,967,604 |
Repayments | (165,061) | (1,926,858) |
Write-offs | 0 | 0 |
Foreign exchange | 39,882 | 383,578 |
Inflation adjustment | (177,646) | (720,568) |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (individually assessed) | Transfers from Stage 1 to Stage 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 347,830 | 15 |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (individually assessed) | Transfers from Stage 2 to Stage 1 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (45,399) | (44,935) |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (individually assessed) | Transfers from Stage 1 or 2 to Stage 3 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | (4,107) | (165,027) |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (individually assessed) | Transfers from Stage 3 to Stage 1 or 2 |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | 0 | (36,530) |
Allowances for ECL | Financial Assets | Stage 2 | Credit risk exposure (individually assessed) | Changes without transfers between Stages |  |  |
Disclosure of impairment loss and reversal of impairment loss [line items] |  |  |
Transfers of financial assets: | $ 653,695 | $ (41,651) |

X
- Definition The amount of credits recovered that is not include in tables about impairment of financial assets. + References No definition available. + Details
Name: | bbar_CreditsRecovered
Namespace Prefix: | bbar_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Decrease Through Repayments, Financial Assets + References No definition available. + Details
Name: | bbar_DecreaseThroughRepaymentsFinancialAssets
Namespace Prefix: | bbar_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The decrease in financial assets resulting from write-off. [Refer: Financial assets] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35I -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I_c&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph IG20B -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DecreaseThroughWriteoffFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 25 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35M -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35N -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35N&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35I -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The increase (decrease) in financial assets resulting from foreign exchange. [Refer: Financial assets] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph IG20B -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The increase (decrease) in financial assets resulting from other movements. [Refer: Financial assets] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph IG20B -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35I -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseThroughOtherMovementsFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The increase (decrease) in financial assets resulting from transfers. [Refer: Financial assets] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph IG20B -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35I -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseThroughTransfersFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The increase in financial assets resulting from origination or purchase. [Refer: Financial assets] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph IG20B -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35I -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=bbar_FinancialAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bbar_TransferOfFinancialAssetsAxis=bbar_TransfersFromStageOneToStageTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bbar_TransferOfFinancialAssetsAxis=bbar_TransfersFromStageTwoToStageOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bbar_TransferOfFinancialAssetsAxis=bbar_TransfersFromStageOneOrTwoToStageThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bbar_TransferOfFinancialAssetsAxis=bbar_TransfersFromStageThreeToStageOneOrTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bbar_TransferOfFinancialAssetsAxis=bbar_ChangesWithoutTransfersBetweenStagesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis=ifrs-full_FinancialInstrumentsCreditimpairedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_ExpectedCreditLossesCollectivelyAssessedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_ExpectedCreditLossesIndividuallyAssessedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CreditImpairmentOfFinancialInstrumentsAxis=ifrs-full_FinancialInstrumentsNotCreditimpairedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |